DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus

Vaccine

Volumn 15, Issue 10, 1997, Pages 1085-1094

  Cuisinier, A M ^a   Mallet, V ^a   Meyer, A ^a   Caldora, C ^a   Aubert, A ^a  

^a Virbac SA   (France)

Author keywords

DNA immunization; FIV; Vaccine

Indexed keywords

DNA VACCINE; FELINE IMMUNE DEFICIENCY VIRUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAT; CONTROLLED STUDY; DRUG EFFECT; EXPRESSION VECTOR; FELINE IMMUNODEFICIENCY VIRUS; GENE STRUCTURE; IMMUNE RESPONSE; INFECTION PREVENTION; INTRAMUSCULAR DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; VACCINATION; VIRUS INACTIVATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; CATS; FELINE ACQUIRED IMMUNODEFICIENCY SYNDROME; GENE PRODUCTS, ENV; GENE PRODUCTS, GAG; GENES, VIRAL; GENETIC VECTORS; IMMUNODEFICIENCY VIRUS, FELINE; PROVIRUSES; VACCINES, DNA; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES; VIRUS REPLICATION;

EID: 0030741195     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(97)00004-2     Document Type: Article

References (39)

1. Bendinelli, M., Pistello, M. and Lombardi, S. et al. Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen. Clin. Microbiol. Rev. 1995, 8, 87-112
2. Pedersen, N.C. Feline immunodeficiency virus infection. In: Animal Model in AIDS (Eds Schellekers, H. and Horzinek, M.C.). Elsevier, Amsterdam, 1991, pp. 165-183
3. Elder, J.H. and Phillips, T.R. Molecular properties of feline immunodeficiency virus. Infectious agents Dis. 1994, 2, 361-374
4. Olmsted, R.A., Hirsch, V.M., Purcell, R.H. and Johnson, P.R. Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses. PNAS 1989, 86, 8088-8092
5. Hosie, M.J., Osborne, R., Reid, G., Neil, J.C. and Jarrett, O. Enhancement after feline immunodeficiency virus vaccination. Vet. Immunol. Immunopathol. 1992, 35, 191-197
6. Yamamoto, J.K., Okuda, T. and Ackley, C.D. et al. Experimental vaccine protection against feline immunodeficiency virus. AIDS 1991, 7, 911-922
7. Yamamoto, J.K., Hohdatsu, T. and Olmsted, R.A. et al. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus. J. Virol. 1993, 67, 601-605
8. Hosie, M.J. The development of a vaccine against feline immunodeficiency virus. Br. Vet. J. 1994, 150, 25-39
9. Hohdatsu, T., Pu, R., Torres, B., Trujillo, S., Gadner, M.B. and Yamamoto, J.K. Passive antibody protection of cats against feline immunodeficiency virus infection. J. Virol. 1993, 67, 2344-2348
10. Pu, R., Okada, S., Little, E.R., Xu, B., Stoffs, W. and Yamamoto, J.K. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies. AIDS 1994, 9, 235-242
11. Tozzini, F., Matteucci, D. and Bandecchi, P. et al. Neutralizing antibodies in cats infected with feline immunodeficiency virus. J. Clin. Microbiol. 1993, 31, 1626-1629
12. Matteucci, D., Pistello, M. and Mazzetti, P. et al. Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies. J. Virol. 1996, 70, 617-622
13. Hoffmann-Lehmann, R., Holznagel, E., Aubert, A., Bauer-Pham, K. and Lutz, H. FIV vaccine. II. Clinical findings, hematological changes and kinetics of blood lymphocyte subsets. Vet. Immmuol. 1995, 46, 115-125
14. Lombardi, S., Garzelli, C. and La Rosa, C. et al. Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. J. Virol. 1993, 67, 4742-4749
15. Lutz, H., Hoffmann-Lehmann, R. and Bauer-Pham, K. et al. FIV vaccine. I. Immune response to recombinant FIV env gene products and outcome after challenge infection. Vet. Immunol. 1995, 46, 115-125
16. Verschoor, E.J., Willemse, M.J. and Stam, J.G. et al. Evaluation of subunit vaccines against feline immunodeficiency virus infection. Vaccine 1995, 14, 285-289
17. Osterhaus, A.D.M.E., Tijiiaar, E. and Huisman, R.C. et al. Accelerated viremia in cats vaccinated with recombinant vaccinia virus expressing envelope glycoprotein of feline immunodeficiency virus. AIDS Res. Human Retroviruses 1996, 12, 437-441
18. Siebelink, K.H.J., Tihaar, E. and Huisman, R.C. et al. Enhancement of feline immunodeficiency virus infection after immunization. J. Virol. 1995, 69, 3704-3711
19. Lutz, H., Hoffmann-Lehmann, R. and Leutnegger, C. et al. Vaccination of cats with recombinant envelope glycoprotein of feline immunodeficiency virus: decreased viral load after challenge infection. AIDS Res. Human Retroviruses 1996, 12, 431-433
20. Wolff, J.A., Malone, R.W. and Williams, P. et al. Direct gene transfer into mouse muscle in vivo. Science 1990, 247, 1465-1468
21. Ulmer, J.B., Donnelly, J.J., Parker, S.E. et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993, 259, 1745-1748
22. Fynan, E.F., Webster, R.G., Fuller, D.H., Haynes, J.R., Santoro, J.C. and Robinson, H.L. DNA vaccines: protective immunizations by parenteral, mucosal and gene-gun inoculations. PNAS 1993, 90, 11478-11482
23. Robinson, H.L., Hunt, L.A. and Webster, R.G. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin expressing plamid DNA. Vaccine 1993, 11, 957-960
24. Xiang, Z.Q., Spitalik, S., Tran, M., Wunner, W.H., Cheng, J. and Ertl, H.C.J. Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus. Virology 1994, 199, 132-140
25. Lu, S., Santoro, J.C., Fuller, D.H., Haynes, J.R. and Robinson, H.L. Use of DNAs expressing HIV-1 env and noninfectious HIV-1 particles to raise antibody responses in mice. Virology 1995, 209, 147-154
26. Okuda, K., Bukawa, H. and Hamajima, K. et al. Induction of potent humoral and cell mediated immune responses following direct injection of DNA encoding HIV type 1 env and rev gene products. AIDS Res. Human Retroviruses 1995, 11, 933-943
27. Wang, B., Ugen, K.E. and Srikantan, V. et al. Gene inoculation generates immune response against human immunodeficiency virus type 1. PNAS 1993, 90, 4156-4160
28. Yasutomi, Y., Robinson, H.L. and Lu, S. et al. Simian immunodeficiency virus specific cytotoxic T lymphocyte induction through DNA vaccination of rhesus monkeys. J. Virol. 1996, 70, 678-681
29. Morikawa, S., Lutz, H., Aubert, A. and Bishop, D.H.L. Identification of a conserved and variable regions in the envelope glycoprotein sequences of two feline immunodeficiency viruses isolated in Zurich. Virus Res. 1991, 21, 53-63
30. Dandekar, S., Beebe, A. and Barlough, M.J. et al. Detection of feline immunodeficiency virus (FIV) nucleic acids in FIV-seronegative cats. J. Virol. 1992, 66, 4040-4049
31. Pancino, G., Camoin, L. and Sonigo, P. Structural analysis of the principal dominant domain of the feline immunodeficiency virus transmembrane glycoprotein. J. Virol. 1995, 69, 2110-2118
32. Gonin, P., Fournier, A., Oualikene, W., Moraillon, A. and Eloit, M. Immunization trial of cats with a replication defective adenovirus type 5 expressing the env gene feline immunodeficiency virus. Vet. Microbiol. 1995, 45, 395-401
33. Burns, D.P.W. and Desrosiers, R.C. A caution on the use of SIV/HIV gag antigen detection systems in neutralization assays. AIDS 1992, 8, 1189-1192
34. Mascola, J.R. and Burke, D.S. Antigen detection in neutralization assays: high levels of interfering anti-p24 antibodies in some plasma. AIDS 1993, 9, 1173-1174
35. Hosie, M.J. and Jarrett, O. Serological responses of cats to feline immunodeficiency virus. AIDS 1990, 4, 215-220
36. Montefieri, D.C., Reimann, K.A., Letvin, N.L., Zhou, J. and Hu, S.L. Studies of complement-activating antibodies in the SIV/ macaque model of acute primary infection and vaccine protection. AIDS Res. Human Retroviruses 1995, 11, 963-970
37. Evans, L.A., Thomso Honneghier, G. and Steimer, K. et al. Antibody-dependant-cellular-cytotoxicity is directed against both the gp120 and gp41 envelope proteins of HIV. AIDS 1989, 3, 273-276
38. Liunggren, K., Brouden, P.A., Morfeldt Manson, L., Jondal, M. and Wahren, B. IgG subclass response to HIV response to HIV in relation to cellular cytotoxicity at different clinical stages. Clin. Exp. Immunol. 1988, 73, 343-347
39. Tyler, D.S., Nastala, C.L. and Stanley, S.D. et al. gp120 specific cellular cytotoxicity in HIV-1 seropositive individuals: evidence for circulating CD16+ effector cells armed in vivo with cytophilic antibodies. J. Immunol. 1989, 142, 1177-1182